Literature DB >> 28598914

Perioperative Temperature Measurement Considerations Relevant to Reporting Requirements for National Quality Programs Using Data From Anesthesia Information Management Systems.

Richard H Epstein1, Franklin Dexter2, Ira S Hofer3, Luis I Rodriguez1, Eric S Schwenk4, Joni M Maga1, Bradley J Hindman2.   

Abstract

BACKGROUND: Perioperative hypothermia may increase the incidences of wound infection, blood loss, transfusion, and cardiac morbidity. US national quality programs for perioperative normothermia specify the presence of at least 1 "body temperature" ≥35.5°C during the interval from 30 minutes before to 15 minutes after the anesthesia end time. Using data from 4 academic hospitals, we evaluated timing and measurement considerations relevant to the current requirements to guide hospitals wishing to report perioperative temperature measures using electronic data sources.
METHODS: Anesthesia information management system databases from 4 hospitals were queried to obtain intraoperative temperatures and intervals to the anesthesia end time from discontinuation of temperature monitoring, end of surgery, and extubation. Inclusion criteria included age >16 years, use of a tracheal tube or supraglottic airway, and case duration ≥60 minutes. The end-of-case temperature was determined as the maximum intraoperative temperature recorded within 30 minutes before the anesthesia end time (ie, the temperature that would be used for reporting purposes). The fractions of cases with intervals >30 minutes between the last intraoperative temperature and the anesthesia end time were determined.
RESULTS: Among the hospitals, averages (binned by quarters) of 34.5% to 59.5% of cases had intraoperative temperature monitoring discontinued >30 minutes before the anesthesia end time. Even if temperature measurement had been continued until extubation, averages of 5.9% to 20.8% of cases would have exceeded the allowed 30-minute window. Averages of 8.9% to 21.3% of cases had end-of-case intraoperative temperatures <35.5°C (ie, a quality measure failure).
CONCLUSIONS: Because of timing considerations, a substantial fraction of cases would have been ineligible to use the end-of-case intraoperative temperature for national quality program reporting. Thus, retrieval of postanesthesia care unit temperatures would have been necessary. A substantive percentage of cases had end-of-case intraoperative temperatures below the 35.5°C threshold, also requiring postoperative measurement to determine whether the quality measure was satisfied. Institutions considering reporting national quality measures for perioperative normothermia should consider the technical and logistical issues identified to achieve a high level of compliance based on the specified regulatory language.

Entities:  

Mesh:

Year:  2018        PMID: 28598914     DOI: 10.1213/ANE.0000000000002098

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Perioperative Hypothermia after Transurethral Surgeries: Is it Necessary to Heat the Irrigation Fluids?

Authors:  Evin Koleini; Jared S Cohen; Oussama M Darwish; Leili Pourafkari; Laura Rein; Nader D Nader
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-12-26

2.  Comparison of temporal artery temperature and bladder temperature in the postanesthesia care unit.

Authors:  Stephanie L Bradley; Andrzej P Kwater; Jessica M Cooke; Catherine M Pivalizza; Xu Zhang; Srikanth Sridhar; Sam D Gumbert; Evan G Pivalizza
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-07-15

3.  Validation of a Prediction Model for Intraoperative Hypothermia in Patients Receiving General Anesthesia.

Authors:  Ziyi Dai; Yuelun Zhang; Jie Yi; Yuguang Huang
Journal:  Int J Clin Pract       Date:  2022-09-17       Impact factor: 3.149

4.  Zero-Heat-Flux and Esophageal Temperature Monitoring in Orthopedic Surgery: An Observational Study.

Authors:  Judy Munday; Niall Higgins; Lee Jones; Dimitrios Vagenas; André Van Zundert; Samantha Keogh
Journal:  J Multidiscip Healthc       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.